Laser therapy for hair loss offers a non-drug, noninvasive treatment specifically for females suffering from androgenic alopecia (female pattern baldness).
Laser hair loss therapy is a cutting-edge development in the treatment of a condition for which there are few safe and effective medical options available. It is proven to promote hair growth and reduce the rate of hair loss of females with androgenic alopecia. The device used for the therapy utilizes a fixed schedule of 100 percent computer-controlled low level laser therapy (LLLT) to the scalp area.
This treatment may involve the use of a contoured laser with 82 low-level laser light diodes completely covering the scalp with measured light stimulation. During the treatments, the laser light energy stimulates blood flow and cellular metabolism in the scalp, using a scientific principle called photobiostimulation.
The therapy calls for a class II medical device that is offered to licensed physicians only and available by prescription only. It meets the same FDA laser safety codes as lasers employed in Lasik surgery, laser pain therapy and other medical laser procedures. Unlike lasers that are used to cut, burn, or vaporize hair follicles, unique cold lasers stimulate hair growth with little or no sensation to the patient.
Clinical studies suggest that a twice-a-week 20-minute treatment with the laser over the course of six months produces remarkable results in a vast majority of patients. A 21-month clinical study, sanctioned by the Institutional Review Board (IRB), validated the 10-week results of the laser device, which demonstrated that 92 percent of the subjects experienced an increased hair count of greater than 10 percent, with 57 percent demonstrating an increase of 30 percent.
The therapy calls for a class II medical device that is offered to licensed physicians only and available by prescription only. It meets the same FDA laser safety codes as lasers employed in Lasik surgery, laser pain therapy and other medical laser procedures. Unlike lasers that are used to cut, burn, or vaporize hair follicles, unique cold lasers stimulate hair growth with little or no sensation to the patient.
Clinical studies suggest that a twice-a-week 20-minute treatment with the laser over the course of six months produces remarkable results in a vast majority of patients. A 21-month clinical study, sanctioned by the Institutional Review Board (IRB), validated the 10-week results of the laser device, which demonstrated that 92 percent of the subjects experienced an increased hair count of greater than 10 percent, with 57 percent demonstrating an increase of 30 percent.
After 36 treatments, 97 percent of the subject population demonstrated an increased hair count of not less than 50 percent. No subject in the study experienced any adverse effects from the treatment.
Natasha Achterberg, research coordinator, along with Dr. Grant Koher, principal investigator, performed the FDA study to validate the laser device. While it was difficult to set up the FDA study, Achterberg was involved in interviewing prospective patients, updating medical records, photography, and performing treatments on over 160 women.
‘The study exceeded our expectations’, Achterberg said. ‘All participants regained hair by the tenth week. And amazingly, 77 percent of those participants had hair regrowth of 50 percent or more of their hair and not one of them showed any additional hair loss’.
Achterberg will be conducting consultations and faculty training.
‘The exciting results of the clinical study, and FDA approval, opens the door to new hope for the estimated 27 million women for whom female pattern baldness is a devastating reality’, says Helmur Keidl.
Achterberg also shares Keidl’s excitement over the possibilities the laser gives to women with female pattern baldness. ‘During the study’, she said. ‘Women expressed their gratitude, as they didn’t have any options really to help them. It was amazing to help them through it’.
Some hair restoration clinics have been helping men and women with the latest techniques in hair replacement and restoration procedures for over 30 years, specializing in medical and non-medical treatments for hair loss.
Natasha Achterberg, research coordinator, along with Dr. Grant Koher, principal investigator, performed the FDA study to validate the laser device. While it was difficult to set up the FDA study, Achterberg was involved in interviewing prospective patients, updating medical records, photography, and performing treatments on over 160 women.
‘The study exceeded our expectations’, Achterberg said. ‘All participants regained hair by the tenth week. And amazingly, 77 percent of those participants had hair regrowth of 50 percent or more of their hair and not one of them showed any additional hair loss’.
Achterberg will be conducting consultations and faculty training.
‘The exciting results of the clinical study, and FDA approval, opens the door to new hope for the estimated 27 million women for whom female pattern baldness is a devastating reality’, says Helmur Keidl.
Achterberg also shares Keidl’s excitement over the possibilities the laser gives to women with female pattern baldness. ‘During the study’, she said. ‘Women expressed their gratitude, as they didn’t have any options really to help them. It was amazing to help them through it’.
Some hair restoration clinics have been helping men and women with the latest techniques in hair replacement and restoration procedures for over 30 years, specializing in medical and non-medical treatments for hair loss.
No comments:
Post a Comment